جست‌وجوی استاد و پژوهشگر

• Epidemiology
• Pediatrics
• Congenital Disorders
• +۴ مورد دیگر

Michael Christiansen serves as a Guest researcher in the Department of Biomedical Sciences at the University of Copenhagen, specializing in the Physiology of circulation, kidney and lung research group. His work focuses on epidemiological investigations of congenital disorders and physiological systems using large-scale Danish register data and international collaborations. His primary research spans pediatric epidemiology, congenital anomalies, and physiological mechanisms, with emphasis on fetal/childhood outcomes. Key areas include cardiovascular development, renal-lung interactions in disease, maternal-fetal health determinants, and biomarker identification for metabolic disorders. Recent projects analyze hydrocephalus pathogenesis, obesity-related cardiometabolic risks, and vaccine safety in pregnancy through multi-country cohort studies. Analysis of his 2025 publications reveals heavy reliance on Danish nationwide registries for longitudinal studies of birth defects, neonatal mortality, and chronic disease etiology. His work bridges clinical medicine with population health, frequently addressing preventable adverse outcomes through dietary, immunological, and genetic lenses. Dr. Christiansen operates within the University of Copenhagen's Physiology of circulation, kidney and lung research environment, leveraging institutional strengths in biomedical data science and collaborative networks across European medical research consortia. His laboratory-based and registry-driven approaches integrate molecular physiology with public health analytics.

• Congenital Malformations
• Epidemiology
• Public Health
• +۲ مورد دیگر

Anke Rißmann serves as Associate Professor at Otto von Guericke University Magdeburg's School of Medicine, leading the statewide Malformation Monitoring Saxony-Anhalt initiative from Leipziger Straße 44, Magdeburg. Her role integrates clinical epidemiology with public health policy, coordinating congenital defect surveillance across Saxony-Anhalt's healthcare infrastructure through institutional partnerships and data-driven interventions. Her research centers on birth defect epidemiology and prevention systems, with emphasis on: Population-level congenital malformation tracking Health policy development for pediatric outcomes Multidisciplinary surgical-pediatric collaboration Public health surveillance methodology Regional healthcare system integration Dr. Rißmann directs a comprehensive monitoring program funded by Saxony-Anhalt's health authorities, synthesizing clinical data from 18+ institutions to inform prevention strategies. Her work bridges clinical practice and public health through: Real-time malformation registry management Cross-institutional diagnostic protocol standardization Pediatric surgical outcome analysis Statewide healthcare provider training She maintains critical partnerships with university clinics (Neurosurgery, Oral/Maxillofacial Surgery, Otorhinolaryngology), pediatric hospitals, and regional health offices including Johanniter Hospital Stendal and Magdeburg's Health and Veterinary Office. Current initiatives focus on enhancing early-intervention frameworks for congenital disorders through systematic data collection and clinical network expansion.

Sally Dunwoodieمشاهده پروفایل

استاد

• Congenital Heart Disease
• Birth Defects
• Genetic Research
• +۴ مورد دیگر

Professor Sally Dunwoodie is a leading biomedical researcher at the Victor Chang Cardiac Research Institute and a Professor in the Faculty of Medicine at UNSW Sydney. She has dedicated her career to understanding the genetic and metabolic causes of birth defects, particularly congenital heart disease and vertebral malformations. Her research focuses on developmental biology, genome sequencing, and metabolic disorders. She discovered six of the seven known genes causing vertebral defects and identified NAD deficiency as a preventable cause of birth defects and miscarriage in mice through niacin supplementation. Recent publications highlight her work on SMAD5 variants, NAD metabolism, polygenic risk in congenital heart disease, and bioinformatics tools for variant analysis. Her studies span genetics, developmental biology, and metabolic interventions. Order of Australia (AO) Premier's Prize for Pregnancy Research NHMRC Research Excellence Award Eureka Prize for Birth Defect Research She leads the Chain Reaction Program in Congenital Heart Disease and serves as Deputy Director at the Victor Chang Institute, advancing genetic diagnostic tests and interdisciplinary research on gene-environment interactions.

Vitaly Alexandrovich Postoevمشاهده پروفایل

پژوهشگر

• Public Health
• Epidemiology
• Medical Registries
• +۲ مورد دیگر

Vitaly Alexandrovich Postoev is a researcher affiliated with the Faculty of Health Sciences at UiT The Arctic University of Norway. He completed his doctoral thesis in November 2016 focusing on medical birth registries in Northwestern Russia. His research interests center around public health epidemiology with specific expertise in birth defects surveillance systems and risk factor analysis. His work primarily investigates medical registry applications in the Russian Arctic region, particularly the Kola Peninsula. Dr. Postoev's research demonstrates the effectiveness of medical birth registries initiated in 1997 in Monchegorsk and expanded to all of Murmansk County in 2005 for surveillance of birth defects. His work contributes to understanding maternal and newborn health in challenging Arctic environments.

Kevin Williamsمشاهده پروفایل

استاد

• Hedgehog pathway dysregulation in cancer
• Pharmacologic profiling of cancer cells
• Novel hedgehog pathway inhibitors
• +۴ مورد دیگر

Dr. Kevin Williams is a Professor in the Department of Pharmaceutical Sciences at North Carolina Central University (NCCU), where he serves as the Merck Professor in Integrated Biosciences at the Biomanufacturing Research Institute and Technology Enterprise (BRITE). He is also a member of the Lineberger Comprehensive Cancer Center at UNC and an associate member of the Duke Cancer Institute. Dr. Williams joined NCCU in 2007 as an associate professor and was promoted to full professor in 2018. Dr. Williams earned his Ph.D. in Biochemistry from the University of Cambridge, UK in 1988 and his B.Sc. in Biochemistry (upper second-class honors) from the University of Bath, UK in 1984. Prior to joining NCCU, he spent 15 years in the biopharmaceutical industry, including 6 years at Biogen. Dr. Williams' research primarily focuses on the Hedgehog signaling pathway and its dysregulation in cancer. His laboratory investigates Hedgehog pathway dysregulation in cancer, pharmacologic profiling of cancer cells, the identification and development of novel hedgehog pathway inhibitors, and the role of the hedgehog pathway in alcohol-induced birth defects. He also has significant research interests in Inflammatory Breast Cancer (IBC), including identifying potential therapeutics and raising awareness of this aggressive disease. His publication record demonstrates consistent research activity across multiple disciplines, with recent work spanning cancer therapeutics, developmental biology, and health disparities research. His most recent publications (2022-2025) show a strong focus on hedgehog pathway modulation, inflammatory breast cancer research, and racial disparities in cancer outcomes, with increasing incorporation of computational and AI/ML approaches in drug discovery. NCCU Merck Distinguished Professorship in Integrated Biosciences, 2020 American Association Cancer Research MSI Faculty Scholar in Cancer Research Award (2009, 2010, 2012) Dr. Williams has been continually funded since joining NCCU, with grants from NIH, DoD, Susan G. Komen, and NIIMBL. He leads or co-leads several significant research projects, including the NIH/NIHMD R01 MD017405-01 project addressing health disparities by targeting geographical ancestry-driven variants of immunity. His lab also maintains a strong focus on student training and workforce development, particularly for underrepresented groups in biomedical research. Dr. Williams directs research activities at the BRITE Institute, where his laboratory employs various techniques including high-throughput screening, molecular biology, and in vitro and in vivo cancer models. He collaborates extensively with researchers at UNC and Duke, particularly through the NCCU-DUKE Cancer Disparities Translational Research Partnership.

Brett D. Keiperمشاهده پروفایل

استاد

• mRNA regulation
• Translational control
• Germ cell development
• +۵ مورد دیگر

Brett D. Keiper is a Professor and Graduate Program Director in the Department of Biochemistry and Molecular Biology at the Brody School of Medicine, East Carolina University. He serves on the Graduate Council Executive Committee and administers the Phosphor-Imaging/Fluorescence Imaging (PhIFI) Core Facility, which provides critical imaging services for research laboratories across ECU. Dr. Keiper earned his B.Sc. from Juniata College in 1985 and his Ph.D. from Brandeis University in 1991. He completed postdoctoral training at Boehringer-Ingelheim Pharmaceuticals in Vienna, Austria, and at LSU Health Sciences Center, where he later served as a Research Assistant Professor before joining East Carolina University. His research focuses on mRNA regulation in germ cells, embryos, and tumors, with particular emphasis on how translation initiation factors control cell differentiation, proliferation, and apoptosis. Dr. Keiper's lab primarily uses C. elegans as a model organism to investigate how mRNA selection mechanisms during development can be leveraged to understand and potentially treat diseases like cancer. The transparent nature of C. elegans and its rapid reproduction make it ideal for studying these fundamental biological processes. Analysis of Dr. Keiper's recent publications reveals a consistent focus on translational control mechanisms, particularly the roles of eIF4E isoforms in germ cell development. His work spans from basic molecular mechanisms of mRNA regulation to potential applications in cancer biology, with a strong emphasis on how cells make fate decisions through selective protein synthesis. National Science Foundation Mid-Career Award (MCB-2119959, 2021-2025): 'MCA: Post-nuclear granules traffic mRNAs through helicases and initiation factors to set their translational fates.' Visiting Scientist Fellowship at Mount Desert Island Biological Labs (SCRF 2021-2023): 'Selective control of mRNA translation by eIF4Es, eIF4G, and Vasa during germ cell development.' National Science Foundation grant as co-PI (MCB-1714264, 2022-2025): 'Regulatory mechanism for cellular dedifferentiation in C. elegans germline.' Dr. Keiper actively mentors students and researchers in his lab, focusing on how new proteins lead to new cell fates through selective mRNA translation. His work has significant implications for understanding RNA virus functions, birth defects, and cancer progression. The lab's research methods combine biochemical approaches, microinjection, genetic analysis, and bioinformatics to unravel the complex mechanisms of translational control during development.

• Bone biology
• Musculoskeletal diseases
• Immune disorders
• +۱۰ مورد دیگر

Dr. Yi-Ping Li serves as Dean's Endowed Chair Professor in the Department of Pathology and Laboratory Medicine at Tulane University School of Medicine, where he directs both the Division in Cellular and Molecular Medicine and the Center for Immunity and Musculoskeletal Diseases. Previously, he held the Jay M McDonald Endowed Professor position at the University of Alabama at Birmingham and had appointments at The Forsyth Institute affiliated with Harvard University. Dr. Li's research spans bone biology, musculoskeletal diseases, immune disorders, skeletal development, and cancer bone metastasis. His lab pioneered molecular approaches to osteoclast biology, discovering and characterizing key genes including Cathepsin K, ATP6i, RGS10A, C/EBPα and Gα13. His work has resulted in 6 patents and numerous seminal publications in top journals including Nature Genetics, Nature Communications, and PNAS. His recent publications (2017-2021) demonstrate continued leadership in the field, with research focusing on transcription factors regulating bone formation (RUNX1, Cbfβ), osteoclast signaling pathways, and the intersection of bone biology with immunology and cancer. His work reveals how fundamental discoveries in osteoclast biology translate to therapeutic approaches for inflammatory diseases, periodontitis, and cancer metastasis. Scientific Awards: 2025 Citation Award from Tulane University for highest-cited paper in the previous year Dr. Li maintains active NIH funding through multiple R01 grants totaling over 27 years of continuous NIH support. His laboratory employs animal models to study human disease pathogenesis and develops translational approaches including gene therapy and novel anti-cancer compounds. He collaborates extensively with Dr. Wei Chen and has secondary appointments that facilitate interdisciplinary research. His laboratory, the Center for Immunity and Musculoskeletal Diseases, focuses on 12 major research areas including cancer bone metastasis, vascular disrupting agents, rheumatoid arthritis mechanisms, stem cell reprogramming, craniofacial development, periodontitis in aging, and osteoclast biology. This comprehensive approach positions his work at the forefront of bone-immune-cancer interactions.

• Labor economics
• Public policy economics
• Health economics
• +۵ مورد دیگر

Julian Vedeler Johnsen is an Associate Professor at the University of Bergen specializing in the economics of labour markets, public policies, and health. His research employs rigorous empirical methods using Norwegian register data to address important policy questions across multiple domains including education, criminal justice, and public health. Johnsen's research interests span several interconnected areas: Labor economics, particularly career advancement and competition Public policy evaluation, including welfare and family policies Health economics, with a focus on mental health Education economics, examining school choice and educational outcomes Criminology economics, studying peer effects in prison settings Peer effects across various social contexts His recent publications demonstrate consistent focus on causal identification using quasi-experimental methods. Johnsen frequently publishes in top field journals including the Review of Economic Studies (2024), Economic Journal (2022), and European Journal of Epidemiology (2022), showing the breadth of his research impact across economics and interdisciplinary areas. His work often addresses policy-relevant questions with implications for social welfare programs, educational systems, and public health initiatives. Johnsen has established productive research collaborations with scholars including H. Jansen, L. Khoury, K.G. Salvanes, K. Vaage, A. Willén, and K.V. Løken. His multi-year projects generate multiple publications addressing different aspects of complex research questions, demonstrating methodological rigor and policy relevance.

• Obstetrics
• Gynecology
• Reproductive Medicine
• +۵ مورد دیگر

Professor Nils-Halvdan Morken is a distinguished researcher and clinician at the University of Bergen, Faculty of Medicine, Department of Clinical Science, and serves as a senior physician ( Overlege ) and researcher at Bergen Hospital Trust - Haukeland University Hospital, Women's Clinic. His research primarily focuses on reproductive medicine, with particular emphasis on ovarian function, fertility assessment, pregnancy complications, and maternal-fetal health outcomes. His work often utilizes large population-based datasets from Norway, including the Medical Birth Registry and the Norwegian Mother, Father and Child Cohort Study (MoBa). He has conducted influential research on topics such as the timing of progesterone treatment for preterm birth prevention, the relationship between menarche and fertility, and health outcomes related to Down syndrome and congenital heart defects. His recent publications demonstrate a strong focus on understanding factors affecting fertility, pregnancy outcomes, and long-term maternal health implications. His research often addresses health disparities, particularly among immigrant populations in Norway with studies on antenatal care utilization and ultrasound examination patterns. Norwegian Institute of Public Health funding for research on ovarian function and fertility Telemark Hospital Trust support for various reproductive health studies Research Council of Norway funding (projects 262700 and 320656) European Research Council funding (BIOSFER, 101071773) Professor Morken actively leads significant research initiatives including 'Den norske populasjonsbaserte studien av for tidlig fødsel' (The Norwegian population-based study of preterm birth) and 'Den norske PrELOAD-studien' (The Norwegian PrELOAD study) at the University of Bergen, collaborating with researchers across multiple institutions. His research group focuses on population-based studies of reproductive health, utilizing registry data and cohort studies to address important clinical questions with direct implications for improving women's healthcare in Norway.

Mehmet Can Nacarمشاهده پروفایل

دانشیار

• Obstetrics and Gynecology
• Pregnancy Complications
• Preeclampsia
• +۵ مورد دیگر

Mehmet Can Nacar is an Associate Professor at Adiyaman University Faculty of Medicine, Department of Surgical Medical Sciences. He earned his medical degree from Hacettepe University Faculty of Medicine in 2009 and completed his Obstetrics and Gynecology specialization at Gaziosmanpasa University Faculty of Medicine, Zekai Tahir Burak Training and Research Hospital in 2014. He became an Assistant Professor in August 2017 and was promoted to Associate Professor in March 2024. Dr. Nacar's research focuses on several key areas within obstetrics and gynecology: Pregnancy complications, particularly preeclampsia and hyperemesis gravidarum Genetic polymorphisms related to gynecological conditions, especially primary dysmenorrhea Endometriosis and experimental treatments Fetal development and maternal-fetal health Obstetric emergencies and surgical techniques His work often combines clinical studies with experimental models, particularly rat studies for investigating mechanisms of gynecological conditions and treatments. Dr. Nacar has published extensively in both international and national journals, with a consistent publication record from 2012 through 2023. His research has been cited multiple times, with his 2014 paper 'Underage mothers in Turkey' accumulating 5.4 citations as of October 2023. Among his notable achievements, Dr. Nacar received the Atilla Yıldırım Maternal and Child Health Support Award in 2016 for his research on LIF and VEGF in intrauterine device mechanisms. His research spans both basic science investigations and clinical applications, contributing to the understanding of women's health conditions and potential treatments. Dr. Nacar teaches various courses related to obstetrics and gynecology, including specialized topics on high-risk pregnancies, obstetric emergencies, and pregnancy monitoring. His teaching portfolio demonstrates a comprehensive approach to medical education in women's health, covering both theoretical knowledge and practical clinical skills.

Andrew F Wagnerمشاهده پروفایل

دانشیار

• Clinical Genetics
• Reproductive Genetics
• Genetic Counseling
• +۵ مورد دیگر

Andrew F Wagner, MD is an Associate Professor in the Clinical Genetics division of Obstetrics and Gynecology at Northwestern University's Feinberg School of Medicine. He serves as co-medical director at Reproductive Genetic Innovations in Northbrook, IL, and previously held leadership roles at Insight Medical Genetics in Chicago. His educational background includes: BS: University of Wisconsin-Madison (1995) MD: University of Wisconsin (1999) Obstetrics & Gynecology Residency: Aurora Health Care, Milwaukee (2003) Clinical Genetics Fellowship: University of Pittsburgh (2005) Dr. Wagner's research focuses on reproductive genomic medicine , with pioneering work in expanded carrier screening implementation and prenatal diagnosis of chromosomal abnormalities . His studies address critical gaps in patient perspectives, partner dynamics, and access to genetic services, bridging clinical practice with psychosocial dimensions of care. Board-certified in both Clinical Genetics and Obstetrics/Gynecology, he integrates dual expertise to advance women's health genomics. Recent publications reveal a concentrated emphasis on preconception carrier screening and prenatal cytogenetics , demonstrating methodological rigor through randomized trials and case analyses. His work consistently addresses real-world barriers to genetic service utilization while exploring novel diagnostic findings like mosaic chromosome abnormalities. His scientific recognition includes: Three consecutive Outstanding Teacher Awards from Feinberg School of Medicine (2017-2020) UME Gold and Silver Awards for medical education excellence (2022-2023) Dr. Wagner actively shapes medical education as director of OB/GYN Grand Rounds since 2022 and teaches across multiple training programs. His professional leadership extends to presidency of the Central Association of Obstetricians and Gynecologists (2022-2024), where he chairs program committees and drives educational initiatives. He maintains active roles in seven professional societies including the American College of Medical Genetics and Genomics. He co-directs Reproductive Genetic Innovations, a clinical practice specializing in advanced reproductive genetic diagnostics and counseling services.

• Molecular Biology
• Cellular Biology
• Developmental Biology
• +۶ مورد دیگر

Sung-Eun Kim is a Research Assistant Professor in the Department of Molecular Biosciences within the College of Natural Sciences at The University of Texas at Austin. With a strong academic background from Yonsei University in South Korea where they earned their Bachelor's, Master's, and Ph.D. degrees, Dr. Kim has established a research career focused on developmental biology and cellular signaling pathways. Dr. Kim's educational journey began at Yonsei University where they completed a Bachelor of Science in 2002, followed by a Master of Science in 2004, and ultimately a Ph.D. in 2008. Their academic path then led them to Boston Children's Hospital/Harvard Medical School for postdoctoral training before joining the University of Texas system. Dr. Kim's research program centers on understanding the molecular mechanisms underlying neural tube defects (NTDs), with particular focus on how signaling pathways including Wnt, Sonic hedgehog (SHH), PCP, and folate one-carbon metabolism contribute to proper neural tube closure during embryonic development. Their laboratory employs a diverse array of techniques including cell culture, biochemical assays, molecular and cell biological approaches, and mouse genetics to investigate these critical developmental processes. A key aspect of their current work involves building expertise in mouse embryology to better model human neural tube defects. Analysis of Dr. Kim's publication record reveals a consistent research trajectory spanning developmental biology, cellular signaling, and disease mechanisms. Early work focused on Wnt and Ras-ERK signaling cross-regulation in colon cancer models, while more recent publications demonstrate a shift toward understanding the genetic basis of neural tube defects. Their research bridges basic molecular mechanisms with clinical applications, particularly in understanding how genetic variants contribute to developmental disorders. IUBMB 2018 travel grant award Postdoctoral Fellowship, National Research Foundation (NRF), South Korea (2009-2010) Dr. Kim's research program has been supported through various institutional mechanisms at UT Austin and previously through competitive fellowships. Their work on neural tube defects represents an important contribution to understanding the genetic and molecular basis of these common birth defects, with potential implications for prevention strategies. The laboratory maintains active collaborations with clinical researchers studying human neural tube defect cases. Dr. Kim's laboratory focuses on neural tube defect research using both mouse models and cellular systems. Their work integrates genetic, molecular, and developmental approaches to understand how signaling pathways coordinate during embryonic development. The lab has particular expertise in Wnt receptor complex regulation and its role in developmental processes.

Aarno Palotieمشاهده پروفایل

پژوهشگر

• Genomics
• Neurogenetics
• Psychiatric Genetics
• +۷ مورد دیگر

Dr. Aarno Palotie is a Research Director at the Finnish Institute of Molecular Medicine , affiliated with the University of Helsinki. He leads the Center of Excellence in Complex Disease Genetics and serves as a supervisor in multiple doctoral programs including Brain & Mind , Clinical Research , and Population Health . Palotie maintains external affiliations as an Associate Member at the Broad Institute of MIT and Harvard and Group Leader at Massachusetts General Hospital since 2013. Research Focus: The genomics of neurological and neuropsychiatric disorders constitutes Palotie’s core research domain, with specific expertise in biomedical sciences and neurogenetics . His work spans polygenic risk scores for schizophrenia, traumatic brain injury pathways, Alzheimer’s biomarkers , and cardiovascular genetic mechanisms . Recent publications highlight his contributions to metabolomic disease mapping , synaptic pathway analysis , and population-specific genetic architectures . Scientific Recognition: 2022: European Society of Human Genetics (ESHG) Award 2023: Media Industry Award for Health Sector Influence 2016: Helsinki City Science Award 2016/2022: Order of the White Rose of Finland 2022: Honorary Doctorate Academic Engagement: Palotie serves as editorial reviewer for Nature Genetics and Annals of Neurology , and participates in 32 international academic visits . He chairs the Galien Foundation Board (2025-2029) and advises THL (National Institute for Health and Welfare) Finland’s 2025-2029 strategic committee.

Jongeun Rheeمشاهده پروفایل

استادیار

• Cancer Epidemiology
• Environmental Epidemiology
• Occupational Epidemiology
• +۴ مورد دیگر

Jongeun Rhee is an Assistant Professor in the Department of Surgery at the Uniformed Services University of the Health Sciences (USUHS) School of Medicine, Bethesda, MD, with primary research focus on environmental and occupational epidemiology related to cancer risk. Her work integrates military health contexts, particularly examining exposures to firefighting agents and occupational hazards among service members. Dr. Rhee's educational background includes a Sc.D. and M.S. in Environmental Health from Harvard T.H. Chan School of Public Health, with dual bachelor's degrees in Environmental Health and Life Sciences from Korea University. Her postdoctoral training was completed at the National Cancer Institute's Occupational and Environmental Epidemiology Branch. Her research program centers on cancer epidemiology, with emphasis on genitourinary cancers (prostate and kidney), environmental carcinogens like PFAS, heavy metals, and air pollution. She develops military-specific exposure assessment tools including job exposure matrices for service-related hazards. Current work examines PFAS exposure in military populations and its association with testicular and renal cancers. Analysis of her 15 most recent publications reveals strong thematic focus on environmental exposures (particularly PFAS) and cancer outcomes across multiple organ systems, with increasing emphasis on military populations and multi-ethnic cohorts. Her methodology combines advanced exposure assessment with molecular epidemiology approaches. National Cancer Institute Division of Cancer Epidemiology and Genetics Cancer Health Disparities Award (2022) National Institutes of Health Pamela Anne Cafritz Renal Cell Carcinoma Award (2020) NCI Director's Award (2022) American Association for Cancer Research Scholar-in-Training Award (2022) NIH Award to Mentor Undergraduate Scholars (2024) Dr. Rhee leads multiple NIH-funded projects examining military carcinogens and environmental cancer risks. She mentors early-career researchers through NIH scholarship programs and collaborates extensively with NCI investigators. Her work bridges environmental health sciences with clinical oncology, particularly in military healthcare contexts.

Simon Chong Chuمشاهده پروفایل

پژوهشگر ارشد

• Computational Biology
• Genomics
• Transposable Elements
• +۳ مورد دیگر

Simon Chong Chu, Ph.D. serves as a Caspar Wistar Fellow in the Molecular and Cellular Oncogenesis Program at The Wistar Institute. A computational biologist specializing in genomic repeats research, Chu develops innovative computational methods to investigate transposable elements and their critical roles in human health and disease. Chu's research interests focus on genomic repeats—including transposable elements (TEs), short and long tandem repeats, and large satellite repeats—that constitute over half of the human genome. His work integrates systems biology with cutting-edge genomics to uncover how these elements influence development, evolution, and disease processes. He has developed computational tools like xTea, REPdenovo, GINDEL, SpliceJumper, GAPPadder, and TrapHunter that have been widely adopted across diverse research contexts. Chu's publication record demonstrates expertise in both cancer genomics and computational methodology development. His recent work examines retroelement contributions to birth defects and childhood cancers, the landscape of human SVA retrotransposons, and comprehensive identification of transposable element insertions using multiple sequencing technologies. His research bridges computational innovation with biological discovery, particularly in understanding how genomic repeats evade suppression mechanisms and contribute to disease states. Chu earned his Ph.D. in Computer Science and Engineering from the University of Connecticut and completed postdoctoral training in the Department of Biomedical Informatics at Harvard Medical School. Prior to joining The Wistar Institute in 2025, he worked as a principal scientist at ROME Therapeutics, where he contributed to clinical drug discovery.